Prothrombin Time (PT) and International Normalized Ratio (INR) are blood tests that evaluate how quickly your blood forms a clot. They focus mainly on the “extrinsic” and “common” clotting pathways, which depend on several clotting proteins (factors) made by the liver—especially factors I (fibrinogen), II (prothrombin), V, VII, and X. Many of these factors require vitamin K to work properly.

PT is reported in seconds and reflects the time it takes for your blood to clot in the lab after specific reagents are added. Because PT results can vary between laboratories, INR standardizes the PT result so it can be compared reliably across different labs and test methods. This is why INR is the preferred value for monitoring people taking the blood thinner warfarin (Coumadin).

In plain language, PT/INR results help answer: “Is my blood clotting too slowly, too quickly, or about right?”

• Higher PT / higher INR usually means your blood is taking longer to clot (higher bleeding risk). This can occur with warfarin use, liver disease, vitamin K deficiency, certain medications or supplements, or clotting factor deficiencies.
• Lower INR (or shorter PT) usually means your blood is clotting faster than expected. This can happen if warfarin dosing is too low or if there are factors increasing clotting tendency. (PT/INR is not the main test used to diagnose most “too much clotting” conditions.)

Your clinician interprets PT and INR based on your health situation—especially whether you are taking blood thinners, have liver problems, or have bleeding or clotting symptoms.

PT/INR testing is commonly ordered to monitor and manage medications and to evaluate unexplained bleeding or concerns about liver function and clotting.

Common reasons your doctor may order a PT/INR test include:

• Monitoring warfarin (blood thinners): To ensure the dose is in a safe and effective range—high enough to prevent harmful clots but not so high that it causes bleeding.
• Checking for abnormal bleeding or bruising: Such as frequent nosebleeds, bleeding gums, unusually heavy menstrual bleeding, easy bruising, blood in urine or stool, or prolonged bleeding from cuts.
• Before surgery or an invasive procedure: Especially if you have a history of bleeding, take anticoagulants, have liver disease, or your clinician wants to assess clotting safety.
• Evaluating liver health and liver synthetic function: Because the liver makes many clotting factors, PT/INR may become prolonged in acute or chronic liver disease.
• Assessing vitamin K status: Vitamin K deficiency or poor absorption (for example, due to certain digestive conditions) can raise PT/INR.
• Medication and supplement interactions: Many drugs can affect INR (e.g., some antibiotics, antifungals, amiodarone, seizure medicines) and supplements or diet changes can alter vitamin K balance. PT/INR helps detect these effects.
• Suspected clotting factor problems: Such as inherited or acquired factor deficiencies, or conditions that reduce clotting factors.

If you are taking warfarin, your clinician may recommend PT/INR testing more frequently when starting treatment, changing the dose, adding new medications, changing diet (especially vitamin K-rich foods), or if you have illness that could affect clotting.

• Warfarin (Coumadin) anticoagulation therapy monitoring
• Chronic liver disease (e.g., cirrhosis)
• Acute liver failure or severe hepatitis
• Vitamin K deficiency (including malabsorption or poor dietary intake)
• Disseminated intravascular coagulation (DIC)
• Inherited or acquired clotting factor deficiencies (especially factor VII deficiency)
• Antiphospholipid syndrome (may affect clotting tests in some cases; management often involves anticoagulation monitoring)
• Major bleeding or hemorrhagic complications from anticoagulants

• Safe, effective monitoring of blood thinners (especially warfarin) to prevent stroke, deep vein thrombosis (DVT), or pulmonary embolism (PE)
• Reducing bleeding risk by keeping INR in the prescribed therapeutic range
• Assessing liver synthetic function as part of liver health monitoring
• Pre-procedure safety planning (evaluating clotting status before surgery, dental work, or biopsies)
• Identifying and managing medication, supplement, or diet interactions that affect clotting
• Evaluating unexplained bruising or bleeding to guide further clotting workup